Initial experiences with a new 120 W greenlight™ high-power system for photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia in Korea

Korean Journal of Urology

Volumn 50, Issue 11, 2009, Pages 1089-1094

  Dong, Woo Ko ^a   Byong, Chang Jeong ^b   Hwancheol, Son ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Lasers; Prostatic hyperplasia; Vaporization

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CATHETERIZATION; GREENLIGHT HIGH POWER SYSTEM FOR PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; HEMATURIA; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PHOTOTHERAPY; POSTOPERATIVE PERIOD; POSTVOID RESIDUAL URINE VOLUME; PROSTATE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RETROSPECTIVE STUDY; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE FLOW RATE;

EID: 72849111052     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2009.50.11.1089     Document Type: Article

References (20)

1. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 2008;180: 241-245
2. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000;163:1730-1733 (Pubitemid 30366723)
3. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005;174:1344-1348
4. Hwang CH, Cho CK, Lee YK, Hong SJ. Comparative analysis of short-term efficacy and complication of photoselective vaporization for benign prostatic hyperplasia which was classified by prostate size. Korean J Urol 2007;48:826-831
5. Park JS, Min GE, You CH, Hong B, Kim CS, Ahn H, et al. Comparison of treatment outcomes between photoselective vaporization and transurethral resection of the prostate for benign prostatic hyperplasia. Korean J Urol 2007;48:297-303. (Pubitemid 47007793)
6. Wong C, Araki M, Tonkin JB. High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. J Endourol 2007;21:1141-1144
7. Spaliviero M, Araki M, Page JB, Wong C. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med 2008;40:529-534
8. Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009;23: 495-502.
9. Paick JS, Um JM, Kwak C, Kim SW, Ku JH. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate. Urology 2007;69:859-863
10. Blute ML, Tomera KM, Hellerstein DK, McKiel CF Jr, Lynch JH, Regan JB, et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol 1993;150: 1591-1596
11. Kaplan SA, Te AE. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995;45:566-572
12. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17: 93-96
13. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-1408 (Pubitemid 39249730)
14. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-971 (Pubitemid 41641646)
15. Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008;54:427-437
16. Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008;54:893-901.
17. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention. Eur Urol 2006;50:969-979 (Pubitemid 44486473)
18. Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009;104:820-825
19. Spaliviero M, Araki M, Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 2008;22:2341-2347
20. Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 2006;175:1817-1821